EAU Podcasts

European Association of Urology
  • 3.7 (3)
  • EDUCATION
  • UPDATED BIWEEKLY

This is the official podcast channel of the European Association of Urology and the European School of Urology. The EAU Podcast is your source for the latest information across the full urological spectrum. Take your clinical practice to new heights and tune in!

  1. 6D AGO

    ASCO GU26 special: Prof. Galsky on results of the KEYNOTE-B15 study

    In this episode, UROONCO BCa chief editor Dr Benjamin Pradere (France) sits down with Matthew Galsky, Professor of Medicine at Icahn School of Medicine at Mount Sinai (New York, USA), to discuss the newly published results of the KEYNOTE-B15 trial. This marks a truly pivotal moment for muscle-invasive bladder cancer. The presentation of KEYNOTE-B15 represents one of the most practice-changing advances in localised MIBC management in recent years, opening a new era of peri-operative systemic therapy and renewed hope for our patients. KEYNOTE-B15 is a randomised phase III trial evaluating peri-operative enfortumab vedotin plus pembrolizumab in cisplatin-eligible patients with MIBC. In this in-depth discussion, Prof. Galsky walks us through the scientific rationale behind the study, the key efficacy and safety results, and crucially, how these data are likely to reshape clinical practice, not only in the immediate future but for years to come. A must-listen conversation for urologists and multidisciplinary teams involved in the care of bladder cancer patients. The KEYNOT-B15 study will be also presented and discussed at upcoming EAU26 on Saturday 14th March in the Game Changer Session. Don't miss the chance to hear more on this important study and mark your agenda!  This interview was recorded at ASCO GU26. For more updates on bladder cancer, please visit our educational platform UROONCO BCa. For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

    13 min

  2. FEB 21

    Journal club: The use of antibiotic prophylaxis for ESWL treatment of urolithiasis (APPEAL trial)

    In this Journal Club edition of the EAU Podcast, Prof. Thomas Tailly leads a focused discussion on the recently completed APPEAL trial, a multicentre randomised controlled study evaluating whether routine antibiotic prophylaxis is necessary for patients undergoing extracorporeal shock wave lithotripsy (ESWL). The distinguished panel - Prof. Kari Tikkinen, Prof. Zafer Tandogdu, Dr. Daron Smith, and Dr. Guido Kamphuis - explores the study’s design, recruitment challenges, outcome measures and the rationale behind examining antibiotic use in a procedure historically considered low-risk for infection. They discuss variations in practice across centres, the balance between preventing rare infectious complications and avoiding unnecessary antibiotic exposure, and how the trial contributes valuable evidence in an area with limited high-quality data. Throughout the episode, the panel reflects on how these findings align with current EAU recommendations and considers how the APPEAL trial can support future refinements in guideline statements. With a mix of expert insight, clinical reasoning and constructive debate, this episode offers listeners a clear understanding of the trial’s significance and its potential impact on everyday urological practice. You can find the article to the APPEAL trial here.  For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

    36 min

  3. FEB 14

    Start smart: EU-ACME for young urologists - Understanding EU-ACME / MyCME in daily practice

    In Episode 1, “Understanding EU-ACME / MyCME in daily practice” of the series “Start smart: EU-ACME for young urologists”, Prof. Marek Babjuk, Assoc. Prof. Juan Luis Vásquez, Prof. Giorgio Ivan Russo and Dr. Loïc Baekelandt introduce the EU-ACME programme and its role in supporting structured training and professional development. They clarify key concepts, terminology, and membership types, helping listeners build a strong foundation for engaging with the system. Their discussion highlights how EU-ACME contributes to harmonising education and promoting high standards across European urology. For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

    14 min

  4. FEB 8

    Highlights of 2025 in low- and intermediate-risk prostate cancer

    In this episode, UROONCO PCa associate editor Prof. Claudia Kesch (DE) interviews Dr. Jochen Walz (FR) about the key highlights of 2025 in low- to intermediate-risk prostate cancer. They discuss advances in imaging diagnostics, artificial intelligence and biomarkers, active surveillance, surgical techniques and radiotherapy, as well as what is anticipated in 2026.  Here are the links to the articles and interviews on the trials which were mentioned in this podcast:  OPTIMUM TrialPRIME TrialBARCODE1 studyNeuroSAFE PROOF trial resultsENZARAD trial  For more updates on prostate cancer, please visit our educational platform UROONCO PCa. For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

    21 min

  5. FEB 4

    EAUN edition: From burning to learning: Understanding UTIs

    This EAUN episode is about understanding urinary tract infections (UTIs). Rikke Nygaard Knudsen, Clinical RN, EAUN Board Member and Chair of the Danish National Society, is joined by Susanne Vahr Lauridsen, Clinical RN, Senior Researcher, former EAUN Chair and EAUN guideline group member, for a practical and engaging conversation on everything there is to know about UTIs. Drawing on extensive clinical and guideline experience, they unpack what a UTI really is, why it remains so common, and how to distinguish localised from systemic infections. The discussion brings guideline recommendations to life, with a strong focus on prevention and careful assessment rather than reflex antibiotic use. Particular attention is given to catheter-related UTIs, explaining why intermittent catheterisation should be preferred whenever possible. With clear examples from daily practice, the episode translates EAUN guidance into actionable insights, empowering nurses to make informed decisions and improve patient outcomes. For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

    14 min

  6. JAN 31

    Women in Urology – Dr. Skrodzka and Dr. Stivalet discuss redefining expectations in andrology

    In Episode 10, “My andrologist is a woman: Redefining expectations” of the series “Women in urology: Dare to thrive”, Dr. Marta Skrodzka (GB) and Dr. Nadja Stivalet (FR) explore how being a woman in andrology is reshaping professional practice and patient expectations. Drawing on their clinical experiences, they discuss why female andrologists may offer a different dynamic in consultations, particularly in sensitive conversations around sexuality, fertility and male health. The speakers reflect on trust-building with patients and couples, challenging traditional assumptions about gender roles in andrology. They also address misconceptions about the specialty, emphasising that andrology extends far beyond prostate care and spans all stages of a patient’s life. Through open dialogue, the episode highlights how visibility, communication style and empathy contribute to redefining what patients expect from their andrologist. Together, they make a compelling case for normalising and valuing women’s presence in this traditionally male-associated field. For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

    16 min

  7. JAN 25

    The present and future directions of metastatic prostate cancer treatment

    In this episode, UROONCO PCa Associate Editor Assoc. Prof. Pawel Rajwa (PL) interviews medical oncologist Prof. Silke Gillessen Sommer (CH) about the present and future directions of metastatic prostate cancer treatment. They discuss the greatest survival gains in metastatic prostate cancer over the past decade, triplet therapy in mHSPC and patient selection, the role of PSMA-PET imaging and sequencing of systemic therapies in metastatic prostate cancer, biomarker-driven treatment selection, and finally where the future of metastatic prostate cancer treatment is heading. Here are the links to the articles and event which were mentioned in this podcast:  EORTC GUCG 2238 De-escalate trialCAPItello-281 phase III studyAPCCC (Advanced Prostate Cancer Consensus Conference)For more updates on prostate cancer, please visit our educational platform UROONCO PCa. For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

    24 min

  8. JAN 18

    Public awareness of urinary tract infections and the fight against antimicrobial resistance

    In this episode on “Public awareness of urinary tract infections and the fight against antimicrobial resistance”, Assoc. Prof. Z. Tandoğdu (TR) is joined by Prof. G. Bonkat (CH) and Mrs. J.M. Meijlink (NL) to address one of today’s most pressing global health challenges. UTIs are among the most common bacterial infections worldwide, yet they are often wrongly perceived as minor conditions. This misconception can lead to overuse or misuse of antibiotics, fuelling the rapid spread of antimicrobial resistance. Prof. Bonkat shares insights from the EAU Guidelines on how responsible prescribing and clinical practice can help prevent unnecessary antibiotic use. Mrs. Meijlink shares the patient perspective, stressing the importance of accurate information and clear communication between doctors and patients. Together, the speakers explore how awareness campaigns, education, and collaboration across healthcare and patient communities are essential to reducing the burden of UTIs. They emphasise that antimicrobial resistance already causes millions of deaths each year and requires urgent, coordinated action. The discussion highlights practical steps for clinicians and patients alike, while reminding listeners that sustainable management of UTIs depends on both medical expertise and active public involvement. Acknowledgment This activity is supported by an educational grant from our industry partner - GSK, with no involvement in the programme or speaker selection. For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

    46 min
See All (204)

Ratings & Reviews

3.7
out of 5
3 Ratings

About

This is the official podcast channel of the European Association of Urology and the European School of Urology. The EAU Podcast is your source for the latest information across the full urological spectrum. Take your clinical practice to new heights and tune in!

Information

  • Creator
    European Association of Urology
  • Years Active
    2021 - 2026
  • Episodes
    204
  • Rating
    Clean
  • Copyright
    © 2026 EAU Podcasts
  • Show Website
    EAU Podcasts

You Might Also Like